EDAP TMS reported EUR15.42M in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
AngioDynamics USD 79.43M 3.72M Sep/2025
Boston Scientific USD 5.14B 300M Sep/2026
EDAP TMS EUR 15.42M 1.54M Mar/2026
Henry Schein USD 3.47B 10M Sep/2026
Medtronic USD 9.8B 0 Jun/2026
Plus Therapeutics USD 1.03M 339K Mar/2026
Veracyte USD 151.75M 1.43M Sep/2026